ClinicalTrials.Veeva

Menu

Sinus Balloon Dilation in Pediatric Patients

E

Entellus Medical

Status

Completed

Conditions

Sinusitis

Treatments

Device: XprESS device and PathAssist confirmation tools

Study type

Interventional

Funder types

Industry

Identifiers

NCT02278484
2827-001

Details and patient eligibility

About

Safety and effectiveness of sinus balloon dilation in patients 2-21 years old.

Enrollment

50 patients

Sex

All

Ages

2 to 21 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Patients age ≥ 2 to ≤ 21 years old. Diagnosed with Chronic Rhinosinusitis (CRS). Candidate for trans-nasal balloon sinus dilation.

Exclusion criteria

History of sinus surgery. Recent nasal or head and neck surgery. Fungal sinus disease. Severe asthma. Cystic fibrosis. Immunodeficiency. Craniofacial abnormalities. Pregnancy (current)

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

50 participants in 1 patient group

Balloon Sinus Dilation
Other group
Treatment:
Device: XprESS device and PathAssist confirmation tools

Trial contacts and locations

4

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems